Filter
64
Filtered Results: 64
Text search:
Indian
Council
of
Medical
Research
&
Department
of
Biotechnology
Featured
Recommendations
3
New Publications
14
Language
Document type
No document type
34
Studies & Reports
16
Guidelines
7
Manuals
4
Strategic & Response Plan
2
Situation Updates
1
Countries / Regions
India
27
Nepal
2
Global
2
Bangladesh
2
Thailand
1
Rwanda
1
Syria
1
Nigeria
1
Zimbabwe
1
Philippines
1
Mozambique
1
Cambodia
1
Asia
1
Uganda
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Guidelines
11
Policies
8
Drugs & Medical Equipment
8
Studies & Reports
7
Policies & Guidelines HIV & TB
3
Community Health
3
Disaster Preparedness
2
Laboratory Waste
1
COVID-19
1
Infection Control & Prevention (IPC)
1
Health System Strengthening
1
Capacity Building
1
Waste Management
1
Laboratory Quality Assurance
1
HIV & STI
1
Age & Elderly
1
TB
1
Food Security & Nutrition
1
Toolboxes
Country specific
5
Public Health
3
Preparedness, Response & Risk Communication
3
Preparedness, Response & Risk Communication
2
Studies
2
Country Specific
2
Fair Allocation & Ethical Aspects
2
General documents One Health
2
General
2
Vision Loss & Blindness
2
General Reports
1
Laboratory Guidance
1
Training
1
Chemical Attacks
1
Adults
1
WASH
1
General
1
Clinical Guidelines
1
Prevention & Preparedness
1
Diagnostics & Laboratory Guidance
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Immunization Guidelines
1
Preparedness, Response & Risk Communication
1
Waste Management
1
Ethics
1
Falsified & Substandard
1
Quality Assurance
1
Traditional & Herbal Medicines
1
Waste Managment
1
Zoonoses
1
Nuclear & Chemical Hazards
1
Studies & Reports
1
Studies & Reports
1
Overview, Studies & Reports
1
General Information & Methodology
1
Health Financing Toolbox
1
Women
1
General
1
Alzheimer's Disease & Dementia
1
Global Health Institutions and Stakeholders
1
TB
1
Capacity Building
1
Global Health Ethics
1
SEAR (South-east Asia Region)
1
The GHS Index is intended to be a key resource in the face of increasing risks of high-consequence and globally catastrophic biological events and in light of major gaps in international financing for preparedness. These risks are magnified by a rapidly changing and interconnected world; increasing ...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
This document aims to assist policy‑makers, health care providers and researchers to understand key concepts in health ethics and to identify basic ethical questions surrounding health and health care. It illustrates the challenges of applying ethical principles to global public health and outline...
The message contained in this publication is clear: countries need a
public health system that can respond to the deliberate release of
chemical and biological agents. Regrettable though this message may
be, the use of poison gas in the war between Iraq and the Islamic
Republic of Iran in the 19...
Non-Wood Forest Products 11
Traditional medicine and its use of medicinal plants is dependent on reliable supply of plant materials. The book focuses on the interface between medicinal plant use and conservation of medicinal plants.
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out to ensure that where medicinal plants are taken from the wild, they are taken on a basis that is sust...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
interim guidance, 19 July 2021 (arabic version)
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought...
